[摘要] 目的 探讨降钙素原对全身炎症反应综合征患者病情预后的判断价值。方法 方便选取2015年1月—2017年6月该院收治的81例全身炎症反应综合征患者为研究对象，根据预后将入选病例分为存活组(33例)和死亡组(48例)。两组患者均于ICU入住24 h内抽取静脉血液样本检测血清降钙素原水平，对比观察两组指标差异性。结果 存活组血清降钙素原(3.74±0.81)ng/mL，死亡组血清降钙素原(54.12±16.37)ng/mL，比较差异有统计学意义(P<0.05)。结论 降钙素原在全身炎症反应综合征死亡患者血清中的水平明显高于生存患者，可作为判断全身炎症反应综合征预后的参考指标加以推广使用。

    [关键词] 全身炎症反应综合征；降钙素原；预后；判断价值

    [中图分类号] R725 [文献标识码] A [文章编号] 1674-0742(2017)11(b)-0024-03

    [Abstract] Objective This paper tries to investigate the value of procalcitonin in the prognosis of patients with systemic inflammatory response syndrome. Methods A total of 81 patients with systemic inflammatory response syndrome treated in this hospital from January 2015 to June 2017 were selected. The patients were divided into the survival group (33 cases) and the death group (48 cases) according to prognosis. Two groups of patients were admitted to the ICU in 24 h and venous blood samples were obtained ......